Julie Grant

Julie Grant, a general partner at Canaan Partners with a robust background in healthcare investments from Goldman Sachs and Genentech, shares her dynamic career journey. She highlights the importance of industry connections and reflects on her time at Genentech, emphasizing the complexities of biotech commercialization. Julie discusses Canaan's bold investment strategies in new medicine categories and the significance of innovation in drug development, advocating for contrarian thinking to drive effective therapies forward. Her insights offer a fascinating look into the evolving landscape of healthcare investments.